Molecular Profiling for Druggable Genetic Abnormalities in Carcinoma of Unknown Primary-Reference-Cited by-同舟云学术

Molecular Profiling for Druggable Genetic Abnormalities in Carcinoma of Unknown Primary

Published:2013-05-10 Issue:14 Volume:31 Page:e237-e239
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Tan Daniel S.-W.¹,Montoya Joey¹,Ng Quan-Sing¹,Chan Kian-Sing²,Lynette Oon²,Sakktee Krisna Sai¹,Takano Angela²,Lim Wan-Teck¹,Tan Eng-Huat¹,Lim Kiat-Hon²

Affiliation:

1. National Cancer Centre Singapore, Singapore

2. Singapore General Hospital, Singapore

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2012.44.3937

Reference27 articles.

1. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Pathologic Evaluation of Unknown Primary Cancer

3. Introduction: Unknown Primary Cancer

4. Multicenter Validation of a 1,550-Gene Expression Profile for Identification of Tumor Tissue of Origin

5. MicroRNAs accurately identify cancer tissue origin

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics;ESMO Open;2022-12

2. Magnetic resonance imaging and 18F-fludeoxyglucose positron emission tomography/computed tomography findings of retroperitoneal clear cell carcinoma with an unknown primary site: A case report;Frontiers in Medicine;2022-11-01

3. Neoplasms of Unknown Primary Site;Holland‐Frei Cancer Medicine;2022-10-21

4. SEOM—GECOD clinical guideline for unknown primary cancer (2021);Clinical and Translational Oncology;2022-03-23

5. The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary✰;Seminars in Diagnostic Pathology;2021-11